202 related articles for article (PubMed ID: 7762951)
1. Urinary N-acetyl-beta-glucosaminidase activity in type I diabetes mellitus.
Jones AP; Lock S; Griffiths KD
Ann Clin Biochem; 1995 Jan; 32 ( Pt 1)():58-62. PubMed ID: 7762951
[TBL] [Abstract][Full Text] [Related]
2. Urinary N-acetyl-beta-D-glucosaminidase activity in type I diabetes mellitus.
Mungan N; Yuksel B; Bakman M; Topaloglu AK; Ozer G
Indian Pediatr; 2003 May; 40(5):410-4. PubMed ID: 12768043
[TBL] [Abstract][Full Text] [Related]
3. [Excretion of beta-N-acetylglucosaminidase in urine in type I and type II diabetic patients with and without nephropathy].
Werle E; Bostedt A; Fiehn W; Hasslacher C
Wien Klin Wochenschr Suppl; 1991; 189():59-62. PubMed ID: 1962487
[TBL] [Abstract][Full Text] [Related]
4. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
[TBL] [Abstract][Full Text] [Related]
5. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW
Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570
[TBL] [Abstract][Full Text] [Related]
6. Urinary N-acetyl-beta-D-glucosaminidase activity does not predict development of diabetic nephropathy.
Agardh CD; Tallroth G; Hultberg B
Diabetes Care; 1987; 10(5):604-6. PubMed ID: 3677979
[TBL] [Abstract][Full Text] [Related]
7. Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?
Patrick AW; Oliver MD; Howie AF; Dawes J; Macintyre CC; Frier BM
Diabete Metab; 1990; 16(5):441-7. PubMed ID: 2150050
[TBL] [Abstract][Full Text] [Related]
8. Urinary Lysosomal Enzyme Activities and Albuminuria in Ghanaian Patients with Type 2 Diabetes Mellitus.
Asare-Anane H; Twum F; Kwaku Ofori E; Torgbor EL; Amanquah SD; Osafo C
Dis Markers; 2016; 2016():2810639. PubMed ID: 27594733
[TBL] [Abstract][Full Text] [Related]
9. Renal tubular proteinuria and microalbuminuria in diabetic patients.
Gibb DM; Tomlinson PA; Dalton NR; Turner C; Shah V; Barratt TM
Arch Dis Child; 1989 Jan; 64(1):129-34. PubMed ID: 2923463
[TBL] [Abstract][Full Text] [Related]
10. [Influence of glycemic blood glucose control and incipient diabetic nephropathy on the urinary excretion of N-acetyl-glucosaminidase (NAG) in diabetes mellitus].
Sánchez-Hueso MC; Mateo-Caãs J; Zamora-Madaria E
An Med Interna; 1995 May; 12(5):216-20. PubMed ID: 7669872
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of type IV collagen and laminin in the evaluation of nephropathy in NIDDM: comparison with urinary albumin and markers of tubular dysfunction and/or damage.
Banu N; Hara H; Okamura M; Egusa G; Yamakido M
Diabetes Res Clin Pract; 1995 Jul; 29(1):57-67. PubMed ID: 8593760
[TBL] [Abstract][Full Text] [Related]
12. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.
Basturk T; Altuntaş Y; Kurklu A; Aydin L; Eren N; Unsal A
Ren Fail; 2006; 28(2):125-8. PubMed ID: 16538969
[TBL] [Abstract][Full Text] [Related]
13. Urinary N-acetyl-beta-D-glucosaminidase excretion in insulin-dependent diabetes mellitus: relation to microalbuminuria, retinopathy and glycaemic control.
Watts GF; Vlitos MA; Morris RW; Price RG
Diabete Metab; 1988; 14(5):653-8. PubMed ID: 3234588
[TBL] [Abstract][Full Text] [Related]
14. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.
Vaidya VS; Niewczas MA; Ficociello LH; Johnson AC; Collings FB; Warram JH; Krolewski AS; Bonventre JV
Kidney Int; 2011 Feb; 79(4):464-70. PubMed ID: 20980978
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of urinary N-acetyl-beta-D-glucosaminidase as a marker of early renal damage in patients with type 2 diabetes mellitus.
Bouvet BR; Paparella CV; Arriaga SM; Monje AL; Amarilla AM; Almará AM
Arq Bras Endocrinol Metabol; 2014 Nov; 58(8):798-801. PubMed ID: 25465599
[TBL] [Abstract][Full Text] [Related]
16. [Urinary proteins in patients with diabetes mellitus].
Hofmann W; Guder WG
Klin Wochenschr; 1989; 67 Suppl 17():37-9. PubMed ID: 2472508
[TBL] [Abstract][Full Text] [Related]
17. Effects of pentoxifylline administration on urinary N-acetyl-beta-glucosaminidase excretion in type 2 diabetic patients: a short-term, prospective, randomized study.
Navarro JF; Mora C; Muros M; Maca M; Garca J
Am J Kidney Dis; 2003 Aug; 42(2):264-70. PubMed ID: 12900807
[TBL] [Abstract][Full Text] [Related]
18. Tubular dysfunction in the early stage of diabetic nephropathy.
Tanaka A; Shima K; Fukuda M; Tahara Y; Yamamoto Y; Kumahara Y
Med J Osaka Univ; 1989 Mar; 38(1-4):57-63. PubMed ID: 2485397
[TBL] [Abstract][Full Text] [Related]
19. Urinary biotinidase and alanine excretion in patients with insulin-dependent diabetes mellitus.
Terentyeva EA; Hayakawa K; Tanae A; Katsumata N; Tanaka T; Hibi I
Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):21-4. PubMed ID: 9156561
[TBL] [Abstract][Full Text] [Related]
20. Further evidence for tubular dysfunction in insulin dependent diabetes.
Ratzmann KP; Schimke E; Jung K; Pergande M
J Diabet Complications; 1989; 3(3):167-71. PubMed ID: 2528561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
